Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Health In Tech, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
19.2
19.6
37.6
Cost of revenue
2.3
4.05
12.4
Gross profit
16.8
15.4
20.9
Research and development
2
2.81
1.57
Selling and marketing
3.38
3.16
4.19
General and administrative
8.08
8.48
13.7
Operating expenses
13.5
14.4
19.4
Interest expense
0
0.5
Interest income
0.04
0.12
0.41
Other non-operating income
0.04
-0.1
0.15
Pre-tax income
3.42
0.89
1.67
Income tax
0.95
0.22
0.4
Income from continuing operations
2.48
0.67
Net income to minority interests
1.48
Net income
2.48
0.67
1.28
EPS, basic
0.01
0.02
EPS, diluted
0.01
0.02
Shares, basic (weighted)
51.8
55.8
Shares, diluted (weighted)
53.7
57.7
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
2.42
7.85
7.67
Receivables
2.24
1.65
0.76
Other current assets
0.26
0.79
3.28
Total current assets
6.86
10.8
16.2
Lease right-of-use assets
0.27
0.21
0.14
Total assets
11.5
15.8
23.1
Accounts payable
2.62
1.86
4.19
Total current liabilities
4.78
2.13
5.16
Lease liabilities
0.21
0.14
0.06
Total liabilities
5.41
2.6
5.98
Paid-in capital
2.77
9.17
11.8
Retained earnings
3.27
3.94
5.22
Shareholders' equity
6.09
13.2
17.1
Total equity
6.09
13.2
17.1
Total liabilities and equity
11.5
15.8
23.1
Cash flow statement
FY2024
FY2024
FY2025
Net income
3.96
0.67
1.28
Depreciation and amortization
0.34
0.54
0.9
Stock-based compensation
0.47
1.57
Deferred income tax
0.13
-0.09
0.43
Change in receivables
-1.28
0.59
0.91
Change in payables
2.15
-0.85
2.36
Cash from operations
1.53
2.18
3.13
Cash from investing
-1.94
-0.84
-3.13
Stock issued
8.21
0.02
Cash from financing
1.34
4.09
-0.19
Net change in cash
0.93
5.43
-0.18
Interest paid
0
Income taxes paid
0.48
0.56
0.83
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.86 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
49.2%
Gross profit / revenue.
Pre-tax margin
-14.5%
Pre-tax income / revenue.
Net margin
-11.0%
Net income / revenue.
Operating cash flow margin
-14.2%
Cash from operations / revenue.
Return on assets (ROA)
-13.3%
Net income / average total assets.
R&D / revenue
6.2%
Research and development expense / revenue.
Stock-based pay / revenue
4.7%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
3.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
91.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
35.6%
Gross profit vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
90.7%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
100.0%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
44.0%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
29.9%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
46.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
7.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.18x
Current assets / current liabilities.
Quick ratio
1.51x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.65x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
33.8%
Total liabilities / total assets.
Working capital
$11.8M
Current assets - current liabilities.
Efficiency
Metric
Value
How it is calculated
Asset turnover
1.21x
Revenue / average total assets.
Receivables turnover
4.21x
Revenue / average receivables.
Days sales outstanding
87 days
365 x average receivables / revenue.
Days payables
239 days
365 x average accounts payable / cost of revenue.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.06
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
1.57x
Market cap / revenue.
EV/Sales
1.39x
Enterprise value / revenue.
Earnings yield
-7.0%
Net income / market cap (the inverse of P/E).
What was Health In Tech, Inc.'s revenue in fiscal 2025?
Health In Tech, Inc. reported revenue of $37.6M for fiscal 2025, 91.7% higher than the year before.
Was Health In Tech, Inc. profitable in fiscal 2025?
Yes. Net income was $1.3M, a net margin of 3.4%.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.